Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FBFXK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,795
Award facts
- Contract value 100% obligated
- $15,794.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $15,794.60, was awarded on August 19, 2025, to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG tablets (30-count unit dose). The contract is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a non-set-aside competitive award. The Defense Logistics Agency, which procures medical and pharmaceutical supplies for the Department of Defense, issued this award to support federal healthcare requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, operates as a major pharmaceutical distributor and serves as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle provides comprehensive global pharmaceutical support and enables the contractor to supply a broad range of pharmaceutical products, medical supplies, specialty medications, vaccines, and related commodities to support military healthcare programs worldwide. The underlying IDC represents a flexible contract vehicle designed to serve multiple federal customers, including the Defense Health Agency and U.S. Coast Guard, as part of the broader Pharmaceutical Prime Vendor Global Program structure.
Quick answers
Who was awarded contract SPE2DB25FBFXK?
SPE2DB25FBFXK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 19, 2025.
How much is contract SPE2DB25FBFXK worth?
The government has obligated $15,795 on SPE2DB25FBFXK.
Is contract SPE2DB25FBFXK an order under another contract?
Yes. SPE2DB25FBFXK is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBFXK competed?
The extent of competition for SPE2DB25FBFXK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award